Adiponectin and gastric fundus: A potential target for gut–brain axis dysfunctions

Abstract Adiponectin (ADPN) is a pleiotropic hormone produced by adipose tissue involved in the control of body weight, energy expenditure, and feeding behaviors. Alongside a central effect, ADPN acts on peripheral organs such as the stomach, where it can favor gastric fundus relaxation, reinforcing...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Garella, F. Palmieri, F. Chellini, L. Tarchi, V. Ricca, G. Castellini, C. Sassoli, R. Squecco
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Physiological Reports
Subjects:
Online Access:https://doi.org/10.14814/phy2.70398
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849334598444515328
author R. Garella
F. Palmieri
F. Chellini
L. Tarchi
V. Ricca
G. Castellini
C. Sassoli
R. Squecco
author_facet R. Garella
F. Palmieri
F. Chellini
L. Tarchi
V. Ricca
G. Castellini
C. Sassoli
R. Squecco
author_sort R. Garella
collection DOAJ
description Abstract Adiponectin (ADPN) is a pleiotropic hormone produced by adipose tissue involved in the control of body weight, energy expenditure, and feeding behaviors. Alongside a central effect, ADPN acts on peripheral organs such as the stomach, where it can favor gastric fundus relaxation, reinforcing central satiety signals. Notably, ADPN serum levels are dysregulated in several conditions affecting the gastrointestinal tract. Moreover, altered hormone levels coexist with disorders related to the gut–brain axis malfunctioning, that is, eating disorders and inflammatory bowel diseases. Aiming at considering the effective utility of ADPN in a wide range of clinical conditions, there is an urgent need to identify its targets, clarify its mechanism of action, and downstream effectors. In this view, the present review highlights the advancement in elucidating ADPN effects on gastric fundus, describing its ability to cause morphofunctional alterations of smooth muscle cells, affecting their excitability, contractile machinery, and motor response. This comprehensive overview also provides a critical appraisal on the potential translational applications, including the possibility to consider ADPN as a biomarker for the diagnosis and staging of different clinical conditions. Finally, this review explores the potential employment of ADPN analogues for treating disorders characterized by functional gastric disturbances or altered feeding behaviors.
format Article
id doaj-art-38d0350dce6c42d080e8f79851db2013
institution Kabale University
issn 2051-817X
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series Physiological Reports
spelling doaj-art-38d0350dce6c42d080e8f79851db20132025-08-20T03:45:31ZengWileyPhysiological Reports2051-817X2025-06-011311n/an/a10.14814/phy2.70398Adiponectin and gastric fundus: A potential target for gut–brain axis dysfunctionsR. Garella0F. Palmieri1F. Chellini2L. Tarchi3V. Ricca4G. Castellini5C. Sassoli6R. Squecco7Department of Experimental and Clinical Medicine, Section of Physiological Sciences University of Florence Florence ItalyDepartment of Experimental and Clinical Medicine, Section of Physiological Sciences University of Florence Florence ItalyDepartment of Experimental and Clinical Medicine, Section of Anatomy and Histology, Imaging Platform University of Florence Florence ItalyDepartment of Health Sciences, Psychiatry Unit University of Florence Florence ItalyDepartment of Health Sciences, Psychiatry Unit University of Florence Florence ItalyDepartment of Health Sciences, Psychiatry Unit University of Florence Florence ItalyDepartment of Experimental and Clinical Medicine, Section of Anatomy and Histology, Imaging Platform University of Florence Florence ItalyDepartment of Experimental and Clinical Medicine, Section of Physiological Sciences University of Florence Florence ItalyAbstract Adiponectin (ADPN) is a pleiotropic hormone produced by adipose tissue involved in the control of body weight, energy expenditure, and feeding behaviors. Alongside a central effect, ADPN acts on peripheral organs such as the stomach, where it can favor gastric fundus relaxation, reinforcing central satiety signals. Notably, ADPN serum levels are dysregulated in several conditions affecting the gastrointestinal tract. Moreover, altered hormone levels coexist with disorders related to the gut–brain axis malfunctioning, that is, eating disorders and inflammatory bowel diseases. Aiming at considering the effective utility of ADPN in a wide range of clinical conditions, there is an urgent need to identify its targets, clarify its mechanism of action, and downstream effectors. In this view, the present review highlights the advancement in elucidating ADPN effects on gastric fundus, describing its ability to cause morphofunctional alterations of smooth muscle cells, affecting their excitability, contractile machinery, and motor response. This comprehensive overview also provides a critical appraisal on the potential translational applications, including the possibility to consider ADPN as a biomarker for the diagnosis and staging of different clinical conditions. Finally, this review explores the potential employment of ADPN analogues for treating disorders characterized by functional gastric disturbances or altered feeding behaviors.https://doi.org/10.14814/phy2.70398adiponectinappetiteeating disordersgastric smooth muscleinflammatory bowel disease (IBD)obesity
spellingShingle R. Garella
F. Palmieri
F. Chellini
L. Tarchi
V. Ricca
G. Castellini
C. Sassoli
R. Squecco
Adiponectin and gastric fundus: A potential target for gut–brain axis dysfunctions
Physiological Reports
adiponectin
appetite
eating disorders
gastric smooth muscle
inflammatory bowel disease (IBD)
obesity
title Adiponectin and gastric fundus: A potential target for gut–brain axis dysfunctions
title_full Adiponectin and gastric fundus: A potential target for gut–brain axis dysfunctions
title_fullStr Adiponectin and gastric fundus: A potential target for gut–brain axis dysfunctions
title_full_unstemmed Adiponectin and gastric fundus: A potential target for gut–brain axis dysfunctions
title_short Adiponectin and gastric fundus: A potential target for gut–brain axis dysfunctions
title_sort adiponectin and gastric fundus a potential target for gut brain axis dysfunctions
topic adiponectin
appetite
eating disorders
gastric smooth muscle
inflammatory bowel disease (IBD)
obesity
url https://doi.org/10.14814/phy2.70398
work_keys_str_mv AT rgarella adiponectinandgastricfundusapotentialtargetforgutbrainaxisdysfunctions
AT fpalmieri adiponectinandgastricfundusapotentialtargetforgutbrainaxisdysfunctions
AT fchellini adiponectinandgastricfundusapotentialtargetforgutbrainaxisdysfunctions
AT ltarchi adiponectinandgastricfundusapotentialtargetforgutbrainaxisdysfunctions
AT vricca adiponectinandgastricfundusapotentialtargetforgutbrainaxisdysfunctions
AT gcastellini adiponectinandgastricfundusapotentialtargetforgutbrainaxisdysfunctions
AT csassoli adiponectinandgastricfundusapotentialtargetforgutbrainaxisdysfunctions
AT rsquecco adiponectinandgastricfundusapotentialtargetforgutbrainaxisdysfunctions